In this study, we verified the biological role of CEP55 in breast cancer cells, and the results showed that inhibition of CEP55 significantly reduced the proliferation rate of TNBC cell lines MDA-MB-231 and CAL-148, further reducing the migration and invasion of TNBC cells. Here, CEP55 is linked to breast carcinoma.